At the news
? NEUTRALIMPACT 3/10 CLUSTER filed Sep 1, 2026 at 18:21 ET
Three Xeris Biopharma insiders (McCulloch, Hecht, Pieper) sold a combined $311K in open-market shares on September 1, 2026 at ~$8.49-$8.50 per share. While a cluster of C-suite selling is notable, the total value represents ~0.02% of the $1.5B market cap, well below the 0.1% materiality threshold, and the sales coincide with the stock near multi-year highs, suggesting routine portfolio diversification rather than a bearish signal.
- Three executives, McCulloch, Hecht, Pieper, sold a total of $311,242 in open-market sales on September 1, 2026
- Sales executed at $8.49-$8.50 per share, near XERS's recent highs
- Total sales equal ~0.02% of the $1.5B market cap, well below the 0.1% materiality threshold
- All three sellers have 'See Remarks' titles, likely C-suite or senior operational roles
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access